Spiracur Announces First European Study Evaluating Outcomes for Treatment of...
November 15, 2011 – Spiracur Inc., developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, announced today that a prospective study to evaluate outcomes for the...
View ArticleSpiracur Awarded Three-year New Technology Contract by Novation for Advanced...
December 16, 2011– Spiracur Inc., developer of a small, non-powered innovative negative pressure wound therapy (NPWT) device, today announced that it has been awarded a three-year new technology...
View ArticleSpiracur Launches New Website Featuring Patient-Friendly Animation
March 27, 2012– Spiracur Inc., developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, recently launched a new, enhanced website featuring patient-friendly animation...
View ArticleSpiracur Announces Four New Clinical Abstracts Demonstrating the Value of the...
April 19, 2012– Spiracur Inc., the developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, today announced four new clinical abstracts demonstrating the efficacy and...
View ArticleSpiracur Announces Final Results from Multi-Center Randomized Controlled...
May 8, 2012– Spiracur Inc., the developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, today announced the final results of a 17-center prospective...
View ArticleSpiracur Releases ciSNaP System for Closed Surgical Incisions
May 30, 2012 – Spiracur Inc., the developer of disposable, non-powered negative pressure wound therapy (NPWT) solutions, today announced the introduction of its ciSNaP™ Closed Incision System with its...
View ArticleSpiracur Announces New SNaP Bridge Dressing for Plantar Surface Wound Care
June 26, 2012 – Spiracur Inc., the developer of disposable, non-powered negative pressure wound therapy (NPWT) solutions, today announced the introduction of the SNaP® Wound Care System’s Bridge...
View ArticleSpiracur Awarded NHS Supply Chain Agreement and Drug Tariff Approval in...
September 5, 2012 – Spiracur Inc., the developer of disposable, non-powered negative pressure wound therapy (NPWT) solutions, today announced its inclusion on the NHS Supply Chain Framework Agreement...
View ArticleSpiracur Awarded Two HCPCS Codes for Wound Care Treatment
November 15, 2012 – Spiracur Inc., developer of an ultraportable and disposable negative pressure wound therapy (NPWT) device, announced today that the Department of Health and Human Services, through...
View ArticleSpiracur Announces New SNaP SecurRing Hydrocolloid
March 6, 2013 – Spiracur Inc., developer of the SNaP® Wound Care System, an advanced wound care dressing with the proven efficacy of Negative Pressure Wound Therapy (NPWT), announced today the...
View ArticleSpiracur Highlights New SNaP SecurRing Hydrocolloid for Fast, Easy...
May 2, 2013 – Spiracur Inc. announced today that it is showcasing its full suite of advanced wound care solutions with the proven efficacy of Negative Pressure Wound Therapy (NPWT), including the newly...
View ArticleSpiracur Named a Finalist for the 2013 Red Herring Top 100 North America Award
May 14, 2013 – Spiracur Inc. announced today that it has been selected as a finalist for Red Herring’s Top 100 North America award. The prestigious list honors this year’s most promising private...
View ArticleChronic Wounds and High Risk Surgical Incisions Successfully Treated with...
September 24, 2013 – Spiracur Inc. announced four new clinical abstracts substantiating the viability of the SNaP® Wound Care System for the successful treatment of chronic and acute wounds, including...
View ArticleSpiracur and Century Medical Announce Multiple SNaP System Sales in Japan...
October 14, 2013 – Spiracur Inc. and Century Medical, Inc. (CMI) today announced multiple system sales of the SNaP® Wound Care System to hospitals throughout Tokyo. Japan’s Ministry of Health, Labor...
View ArticleSpiracur Secures TGA Approval for the SNaP Wound Care System and Announces...
January 14, 2014 – Spiracur Inc. today announced that it received Australian Therapeutic Goods Administration (TGA) approval for its SNaP® Wound Care System for the treatment of chronic and acute...
View ArticleSpiracur Announces FDA Clearance of its SNaP Wound Care System Dressings with...
April 1, 2014 – Spiracur today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the SNaP® Wound Care Dressing (with fittings and cartridge removed) for use in a hyperbaric oxygen...
View ArticleMulti-Center RCT Data to be Presented at SAWC Spring Conference Substantiates...
April 22, 2014 – Spiracur announced today that promising data from a multicenter randomized controlled trial (RCT), comparing the treatment of venous leg ulcers (VLU) using the ultraportable...
View ArticleSpiracur Appoints Chris Fashek President & CEO
July 9, 2014 – Spiracur announced today the appointment of Chris Fashek as president and chief executive officer. With two decades of experience leading health care companies, Fashek will oversee...
View ArticleSpiracur Announces Renewal Contract with Novation for Advanced,...
August 7, 2014 – Spiracur today announced it has been awarded a three-year contract renewal with Novation, LLC, one of the healthcare industry’s leading group purchasing organizations. Spiracur will...
View ArticleSpiracur’s SNaP Wound Care System Awarded Coverage by Health Care Services...
Sept. 4, 2014 – Spiracur today announced that Health Care Services Corporation (HCSC) has approved reimbursement coverage of the SNaP® Wound Care System for the treatment of chronic and acute wounds....
View Article
